BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31119567)

  • 1. Breast cancer outcome prediction with tumour tissue images and machine learning.
    Turkki R; Byckhov D; Lundin M; Isola J; Nordling S; Kovanen PE; Verrill C; von Smitten K; Joensuu H; Lundin J; Linder N
    Breast Cancer Res Treat; 2019 Aug; 177(1):41-52. PubMed ID: 31119567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk.
    Klimov S; Miligy IM; Gertych A; Jiang Y; Toss MS; Rida P; Ellis IO; Green A; Krishnamurti U; Rakha EA; Aneja R
    Breast Cancer Res; 2019 Jul; 21(1):83. PubMed ID: 31358020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and Biomarker Supervised Deep Learning for Survival Prediction in Two Multicenter Breast Cancer Series.
    Bychkov D; Joensuu H; Nordling S; Tiulpin A; Kücükel H; Lundin M; Sihto H; Isola J; Lehtimäki T; Kellokumpu-Lehtinen PL; von Smitten K; Lundin J; Linder N
    J Pathol Inform; 2022; 13():9. PubMed ID: 35136676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients.
    Bakre MM; Ramkumar C; Attuluri AK; Basavaraj C; Prakash C; Buturovic L; Madhav L; Naidu N; R P; Somashekhar SP; Gupta S; Doval DC; Pegram MD
    Cancer Med; 2019 Apr; 8(4):1755-1764. PubMed ID: 30848103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
    Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
    BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning based tissue analysis predicts outcome in colorectal cancer.
    Bychkov D; Linder N; Turkki R; Nordling S; Kovanen PE; Verrill C; Walliander M; Lundin M; Haglund C; Lundin J
    Sci Rep; 2018 Feb; 8(1):3395. PubMed ID: 29467373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer.
    Ali HR; Dawson SJ; Blows FM; Provenzano E; Leung S; Nielsen T; Pharoah PD; Caldas C
    J Pathol; 2012 Jan; 226(1):97-107. PubMed ID: 21953021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer.
    Davis J; Martin SG; Patel PM; Green AR; Rakha EA; Ellis IO; Storr SJ
    BMC Cancer; 2014 Dec; 14():995. PubMed ID: 25539577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
    Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
    Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer.
    Nicolò C; Périer C; Prague M; Bellera C; MacGrogan G; Saut O; Benzekry S
    JCO Clin Cancer Inform; 2020 Mar; 4():259-274. PubMed ID: 32213092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.
    Baquero MT; Hanna JA; Neumeister V; Cheng H; Molinaro AM; Harris LN; Rimm DL
    Cancer; 2012 Oct; 118(19):4660-9. PubMed ID: 22359235
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Groheux D; Martineau A; Teixeira L; Espié M; de Cremoux P; Bertheau P; Merlet P; Lemarignier C
    Breast Cancer Res; 2017 Jan; 19(1):3. PubMed ID: 28057031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images.
    Fujima N; Andreu-Arasa VC; Meibom SK; Mercier GA; Truong MT; Hirata K; Yasuda K; Kano S; Homma A; Kudo K; Sakai O
    BMC Cancer; 2021 Aug; 21(1):900. PubMed ID: 34362317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined pN stage and breast cancer subtypes in breast cancer: a better discriminator of outcome can be used to refine the 8th AJCC staging manual.
    Yang ZJ; Yu Y; Chi JR; Guan M; Zhao Y; Cao XC
    Breast Cancer; 2018 May; 25(3):315-324. PubMed ID: 29353447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).
    De Lara S; Nyqvist J; Werner Rönnerman E; Helou K; Kenne Sarenmalm E; Einbeigi Z; Karlsson P; Parris TZ; Kovács A
    BMC Cancer; 2019 Feb; 19(1):187. PubMed ID: 30819139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor-to-breast volume ratio (TBR) predicts cancer-specific survival in breast cancer patients who underwent modified radical mastectomy.
    Wen J; Ye F; Huang X; Li S; Yang L; Xiao X; Xie X
    Tumour Biol; 2016 Jun; 37(6):7493-500. PubMed ID: 26678892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.
    Masarwah A; Auvinen P; Sudah M; Dabravolskaite V; Arponen O; Sutela A; Oikari S; Kosma VM; Vanninen R
    BMC Cancer; 2016 Nov; 16(1):833. PubMed ID: 27806715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiple breast cancer stem cell model to predict recurrence of T
    Qiu Y; Wang L; Zhong X; Li L; Chen F; Xiao L; Liu F; Fu B; Zheng H; Ye F; Bu H
    BMC Cancer; 2019 Jul; 19(1):729. PubMed ID: 31340763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
    Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
    JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.